29 2. DETERMINATION OF THE IPI MEASURE › 2.1. Proportionality and adequacy of a possible IPI measure with regard to the identified measures and practices › 2.1.3. Form of an IPI measure that would be proportionate and would most effectively remedy the level of impairment of access identified, Regulation (EU) 2025/1197

In forcesince 19 Jun 2025

As referred to in recital 20, the Commision concluded in the investigation report that ‘the measures and practices identified in the course of the investigation, put in place by the PRC with respect to the procurement of medical devices, exist and are applied across the entire territory of the PRC. They affect all categories of medical devices in a way that results in a serious and recurrent impairment of access of Union economic operators and Union-made medical devices to the public procurement market for medical devices in the PRC’ [See Section VI of the investigation report.]. The Commission also established that the identified measures and practices mostly result in the exclusion of economic operators and goods in the medical devices sector originating in foreign countries, including those from the Union [See Section V of the investigation report and Section 2.3 of the SWD, where the Commission has established that 87 % of the public tenders for medical devices contain explicit and/or implicit prohibitions to procure imported medical devices or discriminatory requirements affecting such procurement.] thus leading to a siginificant closure of the public procurement market for medical devices in the PRC.